Immunovia AB ( IMMVF) - Stock Earnings
IMMVF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
IMMVF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.9 million USD | 38349 USD |
| 2026Q1 | -1.9 million USD | 38936 USD |
| 2026Q2 | -2.4 million USD | 39237 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
IMMVF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.7 million USD | 156362 USD |
| 2024 | -7.0 million USD | 84640 USD |
| 2025 | -15.8 million USD | 74209 USD |
| 2026 Est. | — | — |
IMMVF
Price: $0.01
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 3.1 million